FACTOR V LEIDEN - MUTATION DETECTION - PCR

Factor V Leiden Mutation Detection - PCR is a specialized molecular diagnostic test used to identify the presence of the Factor V Leiden genetic mutation. This inherited mutation affects the blood clotting process and is one of the most common genetic causes of thrombophilia, a condition that increases the risk of abnormal blood clot formation.

The test uses highly sensitive Polymerase Chain Reaction (PCR) technology to detect specific changes in the Factor V gene. Identifying this mutation helps physicians evaluate an individual's risk of developing deep vein thrombosis (DVT), pulmonary embolism (PE), recurrent miscarriages, and other clotting-related complications.

Benefits of the Test

• Accurately detects Factor V Leiden gene mutation.
• Identifies inherited thrombophilia risk.
• Supports prevention of blood clot-related complications.
• Helps guide long-term medical management.
• Useful for individuals with family history of clotting disorders.
• Assists in pregnancy-related risk assessment.
• Provides reliable genetic diagnosis.
• Supports personalized healthcare planning.

Why Doctors Recommend This Test

Doctors recommend Factor V Leiden Mutation Detection PCR testing for individuals with unexplained blood clots, recurrent deep vein thrombosis, pulmonary embolism, recurrent pregnancy loss, strong family history of thrombophilia, or suspected inherited clotting disorders.

The test helps identify genetic risk factors that may contribute to abnormal clot formation and supports appropriate preventive measures.

Preparation Before Test

• No fasting is required.
• A blood sample is collected for genetic analysis.
• Inform your doctor about personal and family history of clotting disorders.
• Provide details of previous thrombosis episodes if applicable.
• Current medications usually do not affect genetic test results.
• Follow all sample collection instructions provided by healthcare professionals.

Normal Reporting Time

Most Factor V Leiden Mutation Detection - PCR reports at Focus Diagnostics are available within 2–3 hours for specimen processing and molecular workflow initiation. Final genetic analysis, validation, and reporting are generally completed within a few working days depending on laboratory protocols and quality assurance procedures.

Who Should Take This Test?

This test may be recommended for:

• Individuals with unexplained blood clots.
• Patients with deep vein thrombosis (DVT).
• People with pulmonary embolism.
• Individuals with recurrent miscarriages.
• Patients with family history of thrombophilia.
• Young adults with unexplained clotting events.
• Individuals undergoing thrombophilia evaluation.
• Patients referred for inherited clotting disorder assessment.

Detailed Information

Factor V Leiden is a genetic mutation involving the F5 gene, which produces clotting factor V, an important protein involved in blood coagulation. The mutation results in resistance to activated protein C, a natural anticoagulant that normally helps regulate blood clot formation. As a result, affected individuals have an increased tendency to develop abnormal blood clots.

Factor V Leiden is the most common inherited thrombophilia in many populations. Individuals may inherit one copy of the mutation (heterozygous) or two copies (homozygous). Homozygous individuals generally have a higher risk of clotting complications compared to heterozygous carriers.

The mutation is associated with increased risk of deep vein thrombosis, pulmonary embolism, recurrent venous thromboembolism, pregnancy complications, and certain clotting-related disorders. However, not everyone with the mutation will develop blood clots, as environmental and lifestyle factors may also influence risk.

Factor V Leiden Mutation Detection - PCR uses advanced molecular technology to identify the specific genetic alteration responsible for the condition. Because it is a genetic test, results remain constant throughout life and only need to be performed once in most cases.

The test is particularly valuable for individuals with unexplained clotting episodes, strong family history of thrombosis, recurrent pregnancy loss, or thrombotic events occurring at a young age. Early identification allows clinicians to recommend preventive strategies and appropriate medical monitoring.

Results should be interpreted in conjunction with clinical history, coagulation studies, family history, and other thrombophilia investigations. Additional genetic and hematological testing may be recommended depending on the patient's clinical presentation.

At Focus Diagnostics, Factor V Leiden Mutation Detection - PCR testing is performed using advanced molecular diagnostic platforms, validated PCR methodologies, and stringent quality assurance standards to provide accurate, reliable, and clinically meaningful genetic results.